Cite
HARVARD Citation
Westhovens, R. et al. (n.d.). SAT0200 Long term safety of filgotinib in the treatment of rheumatoid arthritis: week 108 data from a phase 2b open-label extension study. Annals of the rheumatic diseases. pp. 960-961. [Online].